Upstream Bio Inc

Upstream Bio, Inc. is a clinical-stage biotechnology company pioneering a novel approach to treating severe respiratory disorders through its development of verekitug, a unique antagonist targeting the receptor for thymic stromal lymphopoietin (TSLP…

Upstream Bio Inc. is advancing its lead candidate, verekitug, in clinical trials for severe inflammatory diseases, including asthma, chronic rhinosinusitis, and chronic obstructive pulmonary disease.

Upstream Bio Inc, a clinical-stage biotech firm, is navigating financial turbulence while advancing promising treatments for inflammatory diseases, including severe respiratory disorders, through ongoing clinical trials.